ANCA-associated pauci-immune necrotizing glomerulonephritis during the treatment with pembrolizumab
Sign Up to like & getrecommendations! Published in 2020 at "Virchows Archiv"
DOI: 10.1007/s00428-020-02882-w
Abstract: Cancer immunotherapy is rapidly changing the treatment paradigm in oncology, and immune checkpoint inhibitors (ICPIs) have been used successfully in a variety of cancer types. Specific side effects termed immune-related adverse events (irAEs) have now… read more here.
Keywords: associated pauci; treatment; treatment pembrolizumab; glomerulonephritis ... See more keywords